Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net income (loss)	$ 6,136	$ (75,424)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	19,285	19,515
Amortization of deferred contract costs	48,392	43,863
Stock-based compensation	53,681	70,264
Allowance for credit losses	2,835	1,026
Net (accretion) amortization of marketable securities	(2,677)	(6,651)
Non-cash operating lease expense	2,700	3,641
Unrealized loss on strategic investments	0	10,311
Other	1,046	1,319
Changes in operating assets and liabilities:
Accounts receivable	8,821	10,364
Prepaid expenses and other assets	(6,805)	(5,508)
Deferred contract costs	(49,542)	(46,626)
Accounts payable, accrued expenses and other liabilities	(9,287)	5,962
Content costs payable	(5,332)	(3,978)
Operating lease liabilities	(731)	(4,523)
Deferred revenue	3,622	19,906
Net cash provided by operating activities	72,144	43,461
Cash flows from investing activities:
Purchases of marketable securities	(137,803)	(239,783)
Proceeds from maturities of marketable securities	169,050	265,350
Purchases of property and equipment	(5,281)	(1,116)
Capitalized software costs	(8,676)	(10,247)
Payments related to asset acquisitions	(1,500)	0
Net cash provided by investing activities	15,790	14,204
Cash flows from financing activities:
Net proceeds from exercise of stock options	62	921
Proceeds from share purchases under employee stock purchase plan	2,560	4,533
Taxes paid related to net share settlement of equity awards	(14,838)	(25,363)
Repurchases of common stock and excise taxes paid	(29,212)	(141,591)
Payments of debt issuance costs	(1,438)	0
Net cash used in financing activities	(42,866)	(161,500)
Effect of foreign exchange rates on cash flows	169	61
Net increase (decrease) in cash, cash equivalents and restricted cash	45,237	(103,774)
Cash, cash equivalents and restricted cash—Beginning of period	191,807	309,552
Cash, cash equivalents and restricted cash—End of period	237,044	205,778
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	235,929	204,563
Restricted cash, current	203	100
Restricted cash, non-current	912	1,115
Total cash, cash equivalents and restricted cash	237,044	205,778
Supplemental disclosures of cash flow information:
Interest paid	44	0
Income taxes paid	1,497	1,165
Supplemental disclosure of non-cash investing and financing activities:
Stock-based compensation in capitalized costs	4,969	6,953
Net change in unrealized gain (loss) on marketable securities	18	89
Increase (decrease) in purchases of property and equipment included in liabilities	(462)	53
Operating lease right-of-use assets exchanged for operating lease liabilities	1,867	9,779
Accrued excise tax on share repurchases	$ 0	$ 944